Covenant Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,169
Closed -$240K 151
2017
Q3
$240K Sell
1,169
-247
-17% -$57.4K 0.15% 127
2017
Q2
$344K Hold
1,416
0.22% 104
2017
Q1
$338K Sell
1,416
-1,884
-57% -$439K 0.23% 102
2016
Q4
$693K Buy
+3,300
New +$684K 0.47% 69

Other funds holding AGN

Covenant Asset Management's AGN Position: Q4 2017 in Review

Covenant Asset Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,169 shares — an estimated $240K sold.

Covenant Asset Management first reported a position in AGN in Q4 2016 and held it in 4 quarters. The position peaked at $693K in Q4 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Covenant Asset Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Covenant Asset Management sold 1,169 Allergan plc shares in Q4 2017, an estimated $240K.
  • Covenant Asset Management first reported a position in Allergan plc in Q4 2016 and held it in 4 quarters.
  • Covenant Asset Management's Allergan plc position peaked at $693K in Q4 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Covenant Asset Management's 13F filing for Q4 2017, filed 12 Jan 2018.